Immunic
IMUX
$1.43
Share price
1.83%
Change (1 day)
-33.15%
Change (1 year)
Categories
Earnings for Immunic (IMUX)
Earnings in 2024 (TTM): -A$0.15 Billion
According to Immunic's latest financial reports the company's current earnings are N/A. , an increase over its 2023 earnings that were of -A$0.16 Billion. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Immunic from 2013 to 2024
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2024  | -A$0.16 Billion | -1.18% |
| 2023 | -A$0.16 Billion | 14.68% |
| 2022 | -A$0.14 Billion | -5.62% |
| 2021 | -A$0.15 Billion | 87.18% |
| 2020 | -A$77.84 Million | 32.24% |
| 2019 | -A$58.87 Million | -9.25% |
| 2018 | -A$64.86 Million | -22.5% |
| 2017 | -A$83.7 Million | 27.6% |
| 2016 | -A$65.6 Million | -20.82% |
| 2015 | -A$82.85 Million | 9.34% |
| 2014 | -A$75.77 Million | 33.05% |
| 2013 | -A$56.95 Million |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 | -A$0.23 Billion | 45.73% | 🇺🇸 USA |